| 标题 |
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Jing Huang; Jianming Xu; Yun Chen; Wu Zhuang; Yiping Zhang; et al 出版日期:2020-05-13 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)